Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Codeine phosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Codeine 30mg tablets
0407020C0AAAEAE
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | 273,011 |
|
Codeine 15mg tablets
0407020C0AAADAD
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | 210,769 |
|
Codeine 15mg/5ml linctus sugar free
0309010C0AAADAD
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | 17,247 |
|
Codeine 60mg tablets
0407020C0AAAFAF
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | 9,770 |
|
Codeine 15mg/5ml linctus
0309010C0AAAAAA
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | 9,126 |
|
Codeine 25mg/5ml oral solution
0407020C0AAABAB
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | 1,402 |
|
Galcodine 15mg/5ml linctus
0309010C0BBAAAD
|
Galcodine | Codeine phosphate | Respiratory System | 90 |
|
Bepro 6.75mg/5ml syrup
0407020C0BBAABA
|
Bepro | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 10mg suppositories
0407020C0AAALAL
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 10mg/5ml oral liquid
0407020C0AAAYAY
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 15mg suppositories
0407020C0AAAQAQ
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 1mg suppositories
0407020C0AABCBC
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 20mg suppositories
0407020C0AABBBB
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 30mg suppositories
0407020C0AAASAS
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 30mg/1ml solution for injection ampoules
0407020C0AAAHAH
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 30mg/5ml oral solution
0407020C0AAAPAP
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 3mg/5ml linctus paediatric
0309010C0AAACAC
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | No data available |
|
Codeine 3mg/5ml linctus paediatric sugar free
0309010C0AAAEAE
|
Codeine phosphate (Cough) | Codeine phosphate | Respiratory System | No data available |
|
Codeine 50mg/5ml oral solution
0407020C0AAANAN
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 5mg suppositories
0407020C0AAAKAK
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 5mg/5ml oral liquid
0407020C0AAAXAX
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 6.75mg/5ml oral solution
0407020C0AABABA
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 60mg/1ml solution for injection ampoules
0407020C0AAAAAA
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 60mg/5ml oral solution
0407020C0AAAVAV
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
|
Codeine 6mg suppositories
0407020C0AAAMAM
|
Codeine phosphate (Analgesic) | Codeine phosphate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.